Search Results 591-600 of 11864 for Ibrance

  1. Medical Research & Education - Mayo Clinic News Network

    There are several breast cancer subtypes. The growth of hormone-dependent breast cancer, the most common subtype, is driven by female hormones. Another common ...

  2. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

    The purpose of this study is to compare the effectiveness of temozolomide to selumetinib for the treatment of patients who have melanoma of the eye that has ...

  3. Intraoperative radiation therapy (IORT) - Doctors & Departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  4. A Study to Evaluate the Use of Organoids to Advance Precision Medicine in Bladder Cancer - Mayo Clinic

    The purpose of this study is to develop patient-derived organoid cultures of urothelial carcinoma from non-invasively obtained urine samples and to characterize ...

  5. Bladder Removal Surgery Clinical Trials - Mayo Clinic Research

    This is a Phase 1 study designed to test the tolerability and feasibility of intravesical therapy with an attenuated Measles virus (MV-NIS) in patients with ...

  6. Oncology (Medical) - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  7. Intraoperative radiation therapy (IORT) - Doctors & Departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  8. Intraoperative radiation therapy (IORT) - Doctors & Departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  9. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Cohorts of patients will receive multiple ascending doses of intravenous DFRF4539A every 3 weeks or weekly. Patients exhibiting acceptable safety and evidence ...

  10. A Study To Investigate Efficacy & Safety Of Intratumoral INT230-6 Compared To US Standard Of Care In Adults With Soft Tissue Sarcomas (INVINCIBLE-3) - Mayo Clinic

    About this study. To compare Overall Survival (OS) for INT230-6 vs United States (US) Standard of Care (SOC) in participants with unresectable or metastatic ...